Faeth Therapeutics, Inc. Proceeds from Issuance of Convertible Preferred Stock
Faeth Therapeutics, Inc. (FTH) reported Proceeds from Issuance of Convertible Preferred Stock of $200.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock · last filed 2026-08-04
- Faeth Therapeutics, Inc. proceeds from issuance of convertible preferred stock for the quarter ending 2026-06-30 was $0.00.
- Faeth Therapeutics, Inc. proceeds from issuance of convertible preferred stock for the quarter ending 2026-03-31 was $200.00M.
- Faeth Therapeutics, Inc. proceeds from issuance of convertible preferred stock for the quarter ending 2025-06-30 was $0.00.
- Faeth Therapeutics, Inc. proceeds from issuance of convertible preferred stock for the quarter ending 2025-03-31 was $0.00.
| Period end | Proceeds from Issuance of Convertible Preferred Stock 3 month | Proceeds from Issuance of Convertible Preferred Stock 6 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $200.00M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $200.00M 10-Q · filed 2026-05-15 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |